AZURRX

First Wave BioPharma is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases... First Wave BioPharma's product portfolio is built around its two proprietary technologies - the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients, and niclosamide, an oral small molecule with anti-inflammatory properties.

Also known as: AzurRx BioPharma, Inc., AzurRx SAS, First Wave BioPharma, First Wave BioPharma, Inc.

Primary location: Boca Raton United States